BRCA1 and neoplasm: BCSCs populations were also implicated in resistance to platinum compounds in a BRCA1/p53-mutated mouse mammary tumor model, being responsible for the development of chemoresistance, clonal evolution, and tumor progression upon chemotherapy treatment [81].